期刊文献+

中药干预氯氮平所致便秘的临床疗效观察 被引量:1

Clinical efficacy of TCM medicine on constipation from clozapine
下载PDF
导出
摘要 目的:观察中药干预氯氮平所致便秘的临床疗效,评估其应用价值。方法:选择2015年5月-2017年5月我院收治的80例出现氯氮平所致便秘的患者作为研究对象,随机将其分为对照组和观察组,对照组的40例患者使用果导片进行治疗,观察组的40例患者使用番泻叶进行治疗。治疗后观察对比两组患者的临床治疗有效率与不良反应发生情况。结果:治疗后观察组患者的临床治疗有效率明显高于对照组,组间差异均具有统计学研究意义,P<0.05;在不良反应方面,观察组患者的发生率略高于对照组,但两组的差异不具有统计学意义,P>0.05。结论:中药番泻叶治疗氯氮平所致便秘的临床治疗效果比西药果导片更佳,虽有不良反应发生,但调整服药剂量后即可缓解,因此临床治疗氯氮平所致的便秘时,可向患者推荐服用番泻叶进行治疗。 Objective:To observe the clinical effect of TCM medicine on constipation from clozapine.Methods:80 patients were randomly selected and divided into the control group and the observation group.40 patients in the control group were given phenolphthalein.40 patients in the observation group were treated with senna.Results:After the treatment,the clinical efficiency in the observation group was significantly higher than the control group(P<0.05).Adverse reactions in the observation group were slightly higher than the control group.The difference between two groups was not statistically significant,P>0.05.Conclusion:The clinical effect of senna on constipation from clozapine is better than that of the western medicine.Although adverse reactions may occur,the symptom can be relieved after adjusting the dosage of senna.Therefore,senna can be applied in treating constipation.
作者 唐燕
出处 《中医临床研究》 2018年第16期84-85,共2页 Clinical Journal Of Chinese Medicine
关键词 中药干预 番泻叶 果导 氯氮平 便秘 临床疗效 TCM medicine intervention Senna Phenolphthalein Clozapine Constipation Clinical efficacy
  • 相关文献

参考文献8

二级参考文献43

  • 1侯成业,赵悦,陈智敏,温乃义,侯书琦,梁英.利培酮和氯氮平治疗精神分裂症对白细胞影响的对照研究[J].医药导报,2015,34(S01):17-18. 被引量:9
  • 2朱美兰,陈有福,巩桂双,罗和春.舒血宁合并抗精神病药物治疗慢性精神分裂症双盲对照研究[J].中国民康医学,1998,13(6):356-356. 被引量:2
  • 3尤黎明.内科护理学[M].北京:人民卫生出版社,2002.464.
  • 4中华医学会精神科分会.中国精神障碍分类与诊断标准[M].3版.济南:山东科学技术出版社,2001:108-1150.
  • 5Coccurello R, Moles A. Potential mechanisms of atypical antip- sychotic-induced metabolic derangement:clues for understand- ing obesity and novel drug designE J~. Pharmacol Ther,2010, 127(3) :210-251.
  • 6John WN, Robert E, Ratner, et open-label, randomized study to al. A 24-week, multicenter, compare changes in glucosemetabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine and risperidone E J ]. J Clin Psychi- atry, 2009,70 ( 4 ) : 487 -499.
  • 7Oliver DH, Fiona PG, Stephanie A, et al. The effect of clozap- ine on factors controlling glucose homeostasis E J ]. J Clin Psy- chiatry ,2012,65 (10) : 1352-1355.
  • 8Howes OD, Smith S, Gaughran FP, et al. The relationship be- tween prolactin levels and glucose homeostasis in antipsychotic treated schizophrenic patients [ J ]. J Clin Psychopharmacol, 2012,26(6) :6294531.
  • 9Marianne UY, Gerald ND, Charles PQ, et al. Association be- tween second-generation antipsychotics and newly diagnosed treated diabetes mellitus : does the effect differ by dose [ J ]. BMC Psychiatry, 2011,11 ( 4 ) : 197-206.
  • 10Vorhora D. Atypical antipsychotic drugs: Current issues of safety and efficacy in the management of schizophrenia or schizoaffective disorder [ J ]. J Psychiatry Neurosci, 2007,32 (5) :331-338.

共引文献422

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部